or
forgot password
  • cancer clinical trials in cooperstown, NY

  • Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer
    Louis Busch Hager Cancer Center at Mary Imogene Bassett Hospital
    Cooperstown, New York 13326
    Lung Cancer
    Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
    Louis Busch Hager Cancer Center at Mary Imogene Bassett Hospital
    Cooperstown, New York 13326
    Breast Cancer
    Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE)
    Bassett Research Institute
    Cooperstown, New York 13326-1394
    Alzheimer Disease
    Anastrozole & ZD1839 Compared With Fulvestrant & ZD1839 in Postmenopausal Women w/ Metastatic Breast Cancer
    Bassett Healthcare Regional Cancer Program at Mary Imogene Bassett Hospital
    Cooperstown, New York 13326
    Breast Cancer
    Imatinib Mesylate or Dasatinib in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
    Mary Imogene Bassett Hospital
    Cooperstown, New York 13326
    Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Phase Chronic Myelogenous Leukemia
    Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)
    Louis Busch Hager Cancer Center at Mary Imogene Bassett Hospital
    Cooperstown, New York 13326
    Kidney Cancer
    S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer
    Bassett Healthcare Regional Cancer Program at Mary Imogene Bassett Hospital
    Cooperstown, New York 13326
    Breast Cancer
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Mary Imogene Bassett Hospital
    Cooperstown, New York 13326
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer
    Bassett Healthcare Regional Cancer Program at Mary Imogene Bassett Hospital
    Cooperstown, New York 13326
    Colorectal Cancer
    Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
    Bassett Healthcare Regional Cancer Program at Mary Imogene Bassett Hospital
    Cooperstown, New York 13326
    Breast Cancer
    Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
    Bassett Healthcare Regional Cancer Program at Mary Imogene Bassett Hospital
    Cooperstown, New York 13326
    Metastatic Cancer, Prostate Cancer
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Mary Imogene Bassett Hospital
    Cooperstown, New York 13326
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer
    Bassett Healthcare Regional Cancer Program at Mary Imogene Bassett Hospital
    Cooperstown, New York 13326
    Prostate Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Mary Imogene Bassett Hospital
    Cooperstown, New York 13326
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Mary Imogene Bassett Hospital
    Cooperstown, New York 13326
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Mary Imogene Bassett Hospital
    Cooperstown, New York 13326
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
    Mary Imogene Bassett Hospital
    Cooperstown, New York 13326
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
    Mary Imogene Bassett Hospital
    Cooperstown, New York 13326
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Mary Imogene Bassett Hospital
    Cooperstown, New York 13326
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    Bortezomib and Dexamethasone With or Without Lenalidomide in Treating Patients With Multiple Myeloma Previously Treated With Dexamethasone
    Mary Imogene Bassett Hospital
    Cooperstown, New York 13326
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Patients With Advanced Non-Small Cell Lung Cancer
    Mary Imogene Bassett Hospital
    Cooperstown, New York 13326
    Non-Small Cell Lung Carcinoma
    Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    Mary Imogene Bassett Hospital
    Cooperstown, New York 13326
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
    Mary Imogene Bassett Hospital
    Cooperstown, New York 13326
    Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement
    Bassett Healthcare Regional Cancer Program at Mary Imogene Bassett Hospital
    Cooperstown, New York 13326
    Breast Cancer, Metastatic Cancer, Multiple Myeloma and Plasma Cell Neoplasm, Musculoskeletal Complications, Pain, Prostate Cancer, Urinary Complications
    Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer
    Bassett Healthcare Regional Cancer Program at Mary Imogene Bassett Hospital
    Cooperstown, New York 13326
    Head and Neck Cancer
    Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab
    Bassett Healthcare Regional Cancer Program at Mary Imogene Bassett Hospital
    Cooperstown, New York 13326
    Breast Cancer, Cardiac Toxicity
    Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy
    Bassett Healthcare Regional Cancer Program at Mary Imogene Bassett Hospital
    Cooperstown, New York 13326
    Chemotherapeutic Agent Toxicity, Colorectal Cancer, Neuropathy, Neurotoxicity
    Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer
    Bassett Healthcare Regional Cancer Program at Mary Imogene Bassett Hospital
    Cooperstown, New York 13326
    Lung Cancer
    Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
    Bassett Healthcare Regional Cancer Program at Mary Imogene Bassett Hospital
    Cooperstown, New York 13326
    Kidney Cancer
    Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
    Mary Imogene Bassett Hospital
    Cooperstown, New York 13326
    Recurrent Melanoma, Stage III Melanoma, Stage IV Melanoma
    Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer
    Bassett Healthcare Regional Cancer Program at Mary Imogene Bassett Hospital
    Cooperstown, New York 13326
    Breast Cancer
    Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    Mary Imogene Bassett Hospital
    Cooperstown, New York 13326
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
    Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
    Mary Imogene Bassett Hospital
    Cooperstown, New York 13326
    Colorectal Cancer
    Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
    Louis Busch Hager Cancer Center at Mary Imogene Bassett Hospital
    Cooperstown, New York 13326
    Anal Cancer
    Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
    Louis Busch Hager Cancer Center at Mary Imogene Bassett Hospital
    Cooperstown, New York 13326
    Breast Cancer
    Melatonin and Radiation Therapy in Treating Patients With Brain Metastases
    Mary Imogene Bassett Hospital
    Cooperstown, New York 13326
    Metastatic Cancer, Radiation Toxicity, Unspecified Adult Solid Tumor, Protocol Specific
    TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer
    The Mary Imogene Bassett Hospital
    Cooperstown, New York 13326
    Ovarian Neoplasms
    Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer
    Louis Busch Hager Cancer Center at Mary Imogene Bassett Hospital
    Cooperstown, New York 13326
    Pancreatic Cancer
    Sorafenib With Either Temsirolimus or Tipifarnib in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed By Surgery
    Mary Imogene Bassett Hospital
    Cooperstown, New York 13326
    Recurrent Melanoma, Stage IV Melanoma
    First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy
    The Mary Imogene Bassett Hospital
    Cooperstown, New York 13326
    Bladder Cancer, Transitional Cell Carcinoma, Metastasis
    Expanded Access Study of Satraplatin Plus Prednisone in Patients With Hormone Refractory Prostate Cancer (HRPC)
    The Mary Imogene Bassett Hospital
    Cooperstown, New York 13326
    Prostate Cancer
    Cognition in the Study of Tamoxifen and Raloxifene
    Bassett Healthcare
    Cooperstown, New York 13326
    Cognition, Aging
    Head to Head Study Epi proColon and FIT
    Bassett Healthcare Center
    Cooperstown, New York 13326
    Colorectal Cancer